

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuron cell-cell adhesion (GO:0007158) | 5.24925114 |
| 2 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.51698419 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.39991468 |
| 4 | limb bud formation (GO:0060174) | 4.37019675 |
| 5 | presynaptic membrane assembly (GO:0097105) | 4.35651355 |
| 6 | dendritic spine morphogenesis (GO:0060997) | 4.27234806 |
| 7 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.21992654 |
| 8 | neuron recognition (GO:0008038) | 4.11898983 |
| 9 | layer formation in cerebral cortex (GO:0021819) | 4.06603079 |
| 10 | dendrite morphogenesis (GO:0048813) | 4.02457205 |
| 11 | vocalization behavior (GO:0071625) | 3.98100360 |
| 12 | presynaptic membrane organization (GO:0097090) | 3.96222854 |
| 13 | response to pheromone (GO:0019236) | 3.86613703 |
| 14 | synaptic vesicle maturation (GO:0016188) | 3.84889113 |
| 15 | axonal fasciculation (GO:0007413) | 3.81093338 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.72416826 |
| 17 | establishment of mitochondrion localization (GO:0051654) | 3.71530760 |
| 18 | synaptic vesicle exocytosis (GO:0016079) | 3.70617149 |
| 19 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.63237906 |
| 20 | neural tube formation (GO:0001841) | 3.55327123 |
| 21 | axon ensheathment in central nervous system (GO:0032291) | 3.52335491 |
| 22 | central nervous system myelination (GO:0022010) | 3.52335491 |
| 23 | locomotory exploration behavior (GO:0035641) | 3.46956198 |
| 24 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.46737636 |
| 25 | protein localization to synapse (GO:0035418) | 3.43353203 |
| 26 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.42849020 |
| 27 | glutamate secretion (GO:0014047) | 3.41278766 |
| 28 | postsynaptic membrane organization (GO:0001941) | 3.40900128 |
| 29 | olfactory bulb development (GO:0021772) | 3.37319971 |
| 30 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.36036252 |
| 31 | negative regulation of neurotransmitter transport (GO:0051589) | 3.32426310 |
| 32 | nucleobase catabolic process (GO:0046113) | 3.31354010 |
| 33 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.26950811 |
| 34 | organelle transport along microtubule (GO:0072384) | 3.26652210 |
| 35 | transmission of nerve impulse (GO:0019226) | 3.25253260 |
| 36 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.22041915 |
| 37 | retinal ganglion cell axon guidance (GO:0031290) | 3.21452289 |
| 38 | proline transport (GO:0015824) | 3.21438623 |
| 39 | spinal cord development (GO:0021510) | 3.20965164 |
| 40 | synapse assembly (GO:0007416) | 3.17539968 |
| 41 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.16793043 |
| 42 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 3.14113101 |
| 43 | neurotransmitter secretion (GO:0007269) | 3.12764989 |
| 44 | sympathetic nervous system development (GO:0048485) | 3.12188989 |
| 45 | cell migration in hindbrain (GO:0021535) | 3.11886186 |
| 46 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.11551812 |
| 47 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.11329978 |
| 48 | exploration behavior (GO:0035640) | 3.10541518 |
| 49 | glutamate receptor signaling pathway (GO:0007215) | 3.09976932 |
| 50 | vesicle transport along microtubule (GO:0047496) | 3.09824276 |
| 51 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.09817830 |
| 52 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.09519157 |
| 53 | mitochondrion transport along microtubule (GO:0047497) | 3.09407354 |
| 54 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.09407354 |
| 55 | gamma-aminobutyric acid transport (GO:0015812) | 3.06117053 |
| 56 | somite development (GO:0061053) | 3.04102018 |
| 57 | apical protein localization (GO:0045176) | 3.01644084 |
| 58 | positive regulation of synapse assembly (GO:0051965) | 3.00113743 |
| 59 | establishment of nucleus localization (GO:0040023) | 2.94716181 |
| 60 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.94415485 |
| 61 | auditory behavior (GO:0031223) | 2.93984859 |
| 62 | cerebellar granule cell differentiation (GO:0021707) | 2.93954829 |
| 63 | cerebral cortex cell migration (GO:0021795) | 2.92352679 |
| 64 | regulation of synaptic vesicle transport (GO:1902803) | 2.88986342 |
| 65 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.87080864 |
| 66 | synaptic transmission, glutamatergic (GO:0035249) | 2.86248753 |
| 67 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.86082557 |
| 68 | synapse organization (GO:0050808) | 2.85024440 |
| 69 | innervation (GO:0060384) | 2.84514402 |
| 70 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.84316270 |
| 71 | forebrain neuron differentiation (GO:0021879) | 2.83266213 |
| 72 | behavioral response to ethanol (GO:0048149) | 2.83034990 |
| 73 | neuron-neuron synaptic transmission (GO:0007270) | 2.82797399 |
| 74 | negative regulation of dendrite development (GO:2000171) | 2.82385111 |
| 75 | central nervous system neuron axonogenesis (GO:0021955) | 2.81769521 |
| 76 | neurotransmitter transport (GO:0006836) | 2.75785882 |
| 77 | limb development (GO:0060173) | 2.74855706 |
| 78 | appendage development (GO:0048736) | 2.74855706 |
| 79 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.74465642 |
| 80 | neuron migration (GO:0001764) | 2.74438145 |
| 81 | atrial cardiac muscle cell action potential (GO:0086014) | 2.74056151 |
| 82 | asymmetric protein localization (GO:0008105) | 2.73844100 |
| 83 | glycerophospholipid catabolic process (GO:0046475) | 2.73626089 |
| 84 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.73246018 |
| 85 | nonmotile primary cilium assembly (GO:0035058) | 2.72446984 |
| 86 | regulation of vesicle fusion (GO:0031338) | 2.71643162 |
| 87 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.70887622 |
| 88 | dendrite development (GO:0016358) | 2.70801326 |
| 89 | regulation of respiratory system process (GO:0044065) | 2.69989770 |
| 90 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.68870730 |
| 91 | regulation of development, heterochronic (GO:0040034) | 2.68551721 |
| 92 | synaptic vesicle endocytosis (GO:0048488) | 2.68536247 |
| 93 | mating behavior (GO:0007617) | 2.68476951 |
| 94 | axon extension (GO:0048675) | 2.68367264 |
| 95 | neuronal action potential propagation (GO:0019227) | 2.68289762 |
| 96 | response to auditory stimulus (GO:0010996) | 2.65889784 |
| 97 | regulation of synapse assembly (GO:0051963) | 2.65182496 |
| 98 | regulation of axon guidance (GO:1902667) | 2.65002278 |
| 99 | adult walking behavior (GO:0007628) | 2.64766391 |
| 100 | kidney morphogenesis (GO:0060993) | 2.64348879 |
| 101 | hippocampus development (GO:0021766) | 2.64069037 |
| 102 | homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) | 2.62353733 |
| 103 | hindbrain development (GO:0030902) | 2.61466308 |
| 104 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.61105923 |
| 105 | protein localization to cilium (GO:0061512) | 2.61016804 |
| 106 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.60759787 |
| 107 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.60510747 |
| 108 | mechanosensory behavior (GO:0007638) | 2.60306300 |
| 109 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.59554410 |
| 110 | axonogenesis (GO:0007409) | 2.58985203 |
| 111 | positive regulation of membrane potential (GO:0045838) | 2.58482421 |
| 112 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.58361545 |
| 113 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.58304792 |
| 114 | dendritic spine organization (GO:0097061) | 2.56989591 |
| 115 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.56787487 |
| 116 | regulation of postsynaptic membrane potential (GO:0060078) | 2.56464297 |
| 117 | clathrin coat assembly (GO:0048268) | 2.56142589 |
| 118 | startle response (GO:0001964) | 2.55586589 |
| 119 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.55091401 |
| 120 | negative regulation of axon guidance (GO:1902668) | 2.53972719 |
| 121 | regulation of synapse structural plasticity (GO:0051823) | 2.53658742 |
| 122 | neuronal ion channel clustering (GO:0045161) | 2.52409591 |
| 123 | regulation of collateral sprouting (GO:0048670) | 2.51085854 |
| 124 | cornea development in camera-type eye (GO:0061303) | 2.50954078 |
| 125 | intraciliary transport (GO:0042073) | 2.50714964 |
| 126 | cardiac ventricle formation (GO:0003211) | 2.50029160 |
| 127 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.49026469 |
| 128 | behavioral response to nicotine (GO:0035095) | 2.48361647 |
| 129 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 2.47881431 |
| 130 | regulation of neurotransmitter levels (GO:0001505) | 2.47704913 |
| 131 | microtubule anchoring (GO:0034453) | 2.47454989 |
| 132 | negative chemotaxis (GO:0050919) | 2.47290653 |
| 133 | fatty acid elongation (GO:0030497) | 2.46692064 |
| 134 | lateral sprouting from an epithelium (GO:0060601) | 2.46522427 |
| 135 | cerebellar Purkinje cell layer development (GO:0021680) | 2.45817551 |
| 136 | regulation of timing of cell differentiation (GO:0048505) | 2.45617164 |
| 137 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.45506950 |
| 138 | ephrin receptor signaling pathway (GO:0048013) | 2.44050720 |
| 139 | membrane hyperpolarization (GO:0060081) | 2.44036686 |
| 140 | nerve growth factor signaling pathway (GO:0038180) | 2.43684748 |
| 141 | positive regulation of exocytosis (GO:0045921) | 2.43029270 |
| 142 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.42807428 |
| 143 | negative regulation of axonogenesis (GO:0050771) | 2.42726986 |
| 144 | axon extension involved in axon guidance (GO:0048846) | 2.41854553 |
| 145 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.41854553 |
| 146 | inner ear receptor stereocilium organization (GO:0060122) | 2.41703110 |
| 147 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.39844278 |
| 148 | negative regulation of axon extension (GO:0030517) | 2.39195133 |
| 149 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.36333028 |
| 150 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.36333028 |
| 151 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.36333028 |
| 152 | cardiac chamber formation (GO:0003207) | 2.34847205 |
| 153 | glial cell proliferation (GO:0014009) | 2.34648316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.01313519 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.75841034 |
| 3 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.45470650 |
| 4 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.51634112 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.40839969 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.32869052 |
| 7 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.28151627 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.22411186 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.22068948 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.19577567 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.06471113 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.01938052 |
| 13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.01727136 |
| 14 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.99050979 |
| 15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.98879550 |
| 16 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.96545762 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.94128609 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.92085295 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.91761123 |
| 20 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.90138119 |
| 21 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.87913523 |
| 22 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.87047151 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.86832899 |
| 24 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.85722387 |
| 25 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.82219505 |
| 26 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.81482631 |
| 27 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.81263247 |
| 28 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.80744751 |
| 29 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.80744751 |
| 30 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.80450005 |
| 31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.79129288 |
| 32 | P300_19829295_ChIP-Seq_ESCs_Human | 1.77677196 |
| 33 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.77497347 |
| 34 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.77332567 |
| 35 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.76534695 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.75900973 |
| 37 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.73932988 |
| 38 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.73611164 |
| 39 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.70717386 |
| 40 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.69830717 |
| 41 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.67280901 |
| 42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.66967363 |
| 43 | FUS_26573619_Chip-Seq_HEK293_Human | 1.66398486 |
| 44 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.65037984 |
| 45 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.61913302 |
| 46 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.60965217 |
| 47 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.58686828 |
| 48 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.58463172 |
| 49 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.57755909 |
| 50 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.54471538 |
| 51 | STAT3_23295773_ChIP-Seq_U87_Human | 1.53346576 |
| 52 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.52912119 |
| 53 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.48990786 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.48585925 |
| 55 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.48447761 |
| 56 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.45440132 |
| 57 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.45008914 |
| 58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.44406473 |
| 59 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.44252813 |
| 60 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.42612006 |
| 61 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.41543549 |
| 62 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.40017405 |
| 63 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.39712932 |
| 64 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.39461455 |
| 65 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.38659001 |
| 66 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.37994163 |
| 67 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.35249763 |
| 68 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.35249763 |
| 69 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.33111713 |
| 70 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.29354290 |
| 71 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.28762471 |
| 72 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.28256141 |
| 73 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.28242024 |
| 74 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.27006270 |
| 75 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24551183 |
| 76 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.23876287 |
| 77 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23063695 |
| 78 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.22770110 |
| 79 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22428192 |
| 80 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.22428192 |
| 81 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.22136382 |
| 82 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.21973265 |
| 83 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.20996007 |
| 84 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.20380519 |
| 85 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19690567 |
| 86 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.19599162 |
| 87 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.19279651 |
| 88 | TP53_16413492_ChIP-PET_HCT116_Human | 1.17775226 |
| 89 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.15777994 |
| 90 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15200868 |
| 91 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.14994529 |
| 92 | * AR_19668381_ChIP-Seq_PC3_Human | 1.12903895 |
| 93 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.12716808 |
| 94 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.11973419 |
| 95 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11792084 |
| 96 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.11511726 |
| 97 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.10357078 |
| 98 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.08663819 |
| 99 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.08377112 |
| 100 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.07834293 |
| 101 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07270795 |
| 102 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.07077757 |
| 103 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.06591831 |
| 104 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.06270956 |
| 105 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06157270 |
| 106 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.05730499 |
| 107 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.05720719 |
| 108 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05388513 |
| 109 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.04987704 |
| 110 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04878351 |
| 111 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.04547161 |
| 112 | EWS_26573619_Chip-Seq_HEK293_Human | 1.03724750 |
| 113 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.03367870 |
| 114 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.02564524 |
| 115 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01364703 |
| 116 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.00481060 |
| 117 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.00021881 |
| 118 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.99834443 |
| 119 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99024833 |
| 120 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.98656537 |
| 121 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.97472923 |
| 122 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96322394 |
| 123 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94525177 |
| 124 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94070147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.81757454 |
| 2 | MP0003880_abnormal_central_pattern | 3.73398128 |
| 3 | MP0004270_analgesia | 3.61273905 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.03879951 |
| 5 | MP0000778_abnormal_nervous_system | 2.83750788 |
| 6 | MP0005423_abnormal_somatic_nervous | 2.65645418 |
| 7 | MP0002063_abnormal_learning/memory/cond | 2.54939870 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 2.48660054 |
| 9 | MP0001486_abnormal_startle_reflex | 2.47280860 |
| 10 | MP0009745_abnormal_behavioral_response | 2.43857315 |
| 11 | MP0002064_seizures | 2.39844422 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.36260877 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.35854359 |
| 14 | MP0000569_abnormal_digit_pigmentation | 2.33401262 |
| 15 | MP0009046_muscle_twitch | 2.30324006 |
| 16 | MP0001968_abnormal_touch/_nociception | 2.10211412 |
| 17 | MP0005645_abnormal_hypothalamus_physiol | 2.09002233 |
| 18 | MP0002102_abnormal_ear_morphology | 2.02863764 |
| 19 | MP0002272_abnormal_nervous_system | 1.99324253 |
| 20 | MP0006292_abnormal_olfactory_placode | 1.90258708 |
| 21 | MP0001440_abnormal_grooming_behavior | 1.89789357 |
| 22 | MP0002733_abnormal_thermal_nociception | 1.86480417 |
| 23 | MP0002184_abnormal_innervation | 1.85861906 |
| 24 | MP0005386_behavior/neurological_phenoty | 1.84850569 |
| 25 | MP0004924_abnormal_behavior | 1.84850569 |
| 26 | MP0010234_abnormal_vibrissa_follicle | 1.84044316 |
| 27 | MP0002557_abnormal_social/conspecific_i | 1.82693038 |
| 28 | MP0002735_abnormal_chemical_nociception | 1.82609218 |
| 29 | MP0002909_abnormal_adrenal_gland | 1.81261463 |
| 30 | MP0005646_abnormal_pituitary_gland | 1.78790241 |
| 31 | MP0003787_abnormal_imprinting | 1.78474548 |
| 32 | MP0006276_abnormal_autonomic_nervous | 1.75797182 |
| 33 | MP0001529_abnormal_vocalization | 1.74566745 |
| 34 | MP0002067_abnormal_sensory_capabilities | 1.71054841 |
| 35 | MP0003329_amyloid_beta_deposits | 1.69788198 |
| 36 | MP0001984_abnormal_olfaction | 1.68151549 |
| 37 | MP0000955_abnormal_spinal_cord | 1.68130871 |
| 38 | MP0003122_maternal_imprinting | 1.63454839 |
| 39 | MP0003690_abnormal_glial_cell | 1.62335618 |
| 40 | MP0006072_abnormal_retinal_apoptosis | 1.60117234 |
| 41 | MP0004885_abnormal_endolymph | 1.58655391 |
| 42 | MP0000920_abnormal_myelination | 1.57093824 |
| 43 | MP0003937_abnormal_limbs/digits/tail_de | 1.56610445 |
| 44 | MP0001970_abnormal_pain_threshold | 1.55640493 |
| 45 | MP0001188_hyperpigmentation | 1.53366417 |
| 46 | MP0008789_abnormal_olfactory_epithelium | 1.52152638 |
| 47 | MP0004742_abnormal_vestibular_system | 1.52136202 |
| 48 | MP0004811_abnormal_neuron_physiology | 1.49974428 |
| 49 | MP0003634_abnormal_glial_cell | 1.49905547 |
| 50 | MP0002882_abnormal_neuron_morphology | 1.49852354 |
| 51 | MP0002638_abnormal_pupillary_reflex | 1.49503018 |
| 52 | MP0002938_white_spotting | 1.48967407 |
| 53 | MP0002736_abnormal_nociception_after | 1.47981161 |
| 54 | * MP0000631_abnormal_neuroendocrine_gland | 1.44029333 |
| 55 | MP0008877_abnormal_DNA_methylation | 1.42812228 |
| 56 | MP0000566_synostosis | 1.39679014 |
| 57 | MP0001501_abnormal_sleep_pattern | 1.38018257 |
| 58 | MP0003755_abnormal_palate_morphology | 1.35385470 |
| 59 | * MP0000049_abnormal_middle_ear | 1.34471339 |
| 60 | MP0003632_abnormal_nervous_system | 1.33829101 |
| 61 | * MP0002233_abnormal_nose_morphology | 1.32962425 |
| 62 | MP0001502_abnormal_circadian_rhythm | 1.32887342 |
| 63 | MP0005409_darkened_coat_color | 1.31747663 |
| 64 | * MP0002152_abnormal_brain_morphology | 1.29683245 |
| 65 | MP0002066_abnormal_motor_capabilities/c | 1.28415155 |
| 66 | MP0010386_abnormal_urinary_bladder | 1.25074608 |
| 67 | MP0005248_abnormal_Harderian_gland | 1.23367110 |
| 68 | MP0002229_neurodegeneration | 1.23331085 |
| 69 | MP0003283_abnormal_digestive_organ | 1.20852214 |
| 70 | MP0005551_abnormal_eye_electrophysiolog | 1.19850349 |
| 71 | MP0003938_abnormal_ear_development | 1.18821010 |
| 72 | MP0003385_abnormal_body_wall | 1.18256198 |
| 73 | * MP0003119_abnormal_digestive_system | 1.17320327 |
| 74 | MP0000537_abnormal_urethra_morphology | 1.16435906 |
| 75 | MP0002822_catalepsy | 1.16022777 |
| 76 | MP0008569_lethality_at_weaning | 1.15982916 |
| 77 | MP0004142_abnormal_muscle_tone | 1.15938514 |
| 78 | MP0005187_abnormal_penis_morphology | 1.13042671 |
| 79 | * MP0002697_abnormal_eye_size | 1.12597929 |
| 80 | MP0004858_abnormal_nervous_system | 1.12572672 |
| 81 | MP0003631_nervous_system_phenotype | 1.12565976 |
| 82 | MP0003633_abnormal_nervous_system | 1.11723967 |
| 83 | * MP0001293_anophthalmia | 1.11131627 |
| 84 | MP0002653_abnormal_ependyma_morphology | 1.10810874 |
| 85 | MP0001905_abnormal_dopamine_level | 1.07802205 |
| 86 | * MP0001286_abnormal_eye_development | 1.04887435 |
| 87 | MP0003183_abnormal_peptide_metabolism | 1.04464321 |
| 88 | * MP0003935_abnormal_craniofacial_develop | 1.04338394 |
| 89 | MP0003890_abnormal_embryonic-extraembry | 1.04331096 |
| 90 | MP0000462_abnormal_digestive_system | 1.02050063 |
| 91 | MP0003136_yellow_coat_color | 1.01907933 |
| 92 | MP0005253_abnormal_eye_physiology | 1.01278822 |
| 93 | MP0000026_abnormal_inner_ear | 1.00163871 |
| 94 | MP0003567_abnormal_fetal_cardiomyocyte | 0.99326237 |
| 95 | MP0003121_genomic_imprinting | 0.99042623 |
| 96 | MP0000534_abnormal_ureter_morphology | 0.96435096 |
| 97 | MP0002752_abnormal_somatic_nervous | 0.95951728 |
| 98 | MP0000604_amyloidosis | 0.95749175 |
| 99 | MP0004043_abnormal_pH_regulation | 0.95136089 |
| 100 | MP0001177_atelectasis | 0.92944893 |
| 101 | MP0002081_perinatal_lethality | 0.92645498 |
| 102 | * MP0003861_abnormal_nervous_system | 0.92330390 |
| 103 | MP0010678_abnormal_skin_adnexa | 0.91517576 |
| 104 | * MP0005391_vision/eye_phenotype | 0.90635897 |
| 105 | MP0002069_abnormal_eating/drinking_beha | 0.90630676 |
| 106 | MP0002090_abnormal_vision | 0.88476409 |
| 107 | MP0000013_abnormal_adipose_tissue | 0.83684677 |
| 108 | MP0001963_abnormal_hearing_physiology | 0.83274162 |
| 109 | MP0000427_abnormal_hair_cycle | 0.83193959 |
| 110 | MP0001485_abnormal_pinna_reflex | 0.82348342 |
| 111 | MP0005195_abnormal_posterior_eye | 0.80558134 |
| 112 | MP0002751_abnormal_autonomic_nervous | 0.80344694 |
| 113 | MP0000428_abnormal_craniofacial_morphol | 0.80309022 |
| 114 | MP0010030_abnormal_orbit_morphology | 0.80026830 |
| 115 | MP0003868_abnormal_feces_composition | 0.78302830 |
| 116 | MP0003195_calcinosis | 0.77729890 |
| 117 | MP0005367_renal/urinary_system_phenotyp | 0.77525620 |
| 118 | MP0000516_abnormal_urinary_system | 0.77525620 |
| 119 | MP0003942_abnormal_urinary_system | 0.77435818 |
| 120 | * MP0001299_abnormal_eye_distance/ | 0.76875370 |
| 121 | * MP0002116_abnormal_craniofacial_bone | 0.76778896 |
| 122 | MP0004133_heterotaxia | 0.74448010 |
| 123 | MP0001944_abnormal_pancreas_morphology | 0.73966994 |
| 124 | MP0000383_abnormal_hair_follicle | 0.73207553 |
| 125 | MP0000647_abnormal_sebaceous_gland | 0.72103444 |
| 126 | MP0005379_endocrine/exocrine_gland_phen | 0.70561700 |
| 127 | MP0002693_abnormal_pancreas_physiology | 0.70351260 |
| 128 | MP0005499_abnormal_olfactory_system | 0.66255795 |
| 129 | MP0005394_taste/olfaction_phenotype | 0.66255795 |
| 130 | MP0002082_postnatal_lethality | 0.65581353 |
| 131 | MP0010770_preweaning_lethality | 0.65581353 |
| 132 | MP0001943_abnormal_respiration | 0.63113090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the corticospinal tract (HP:0002492) | 4.10231190 |
| 2 | Neurofibrillary tangles (HP:0002185) | 3.96208425 |
| 3 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.76491768 |
| 4 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.76491768 |
| 5 | Excessive salivation (HP:0003781) | 3.62711478 |
| 6 | Drooling (HP:0002307) | 3.62711478 |
| 7 | Cerebral inclusion bodies (HP:0100314) | 3.57150653 |
| 8 | Focal seizures (HP:0007359) | 3.41352360 |
| 9 | Insidious onset (HP:0003587) | 3.35648272 |
| 10 | Termporal pattern (HP:0011008) | 3.35648272 |
| 11 | Focal motor seizures (HP:0011153) | 3.31087583 |
| 12 | Akinesia (HP:0002304) | 3.29987316 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 3.27542244 |
| 14 | Epileptic encephalopathy (HP:0200134) | 3.14429808 |
| 15 | Agitation (HP:0000713) | 3.07639598 |
| 16 | Hyperventilation (HP:0002883) | 3.07521592 |
| 17 | Myokymia (HP:0002411) | 3.04274044 |
| 18 | Spastic gait (HP:0002064) | 2.99826056 |
| 19 | Broad-based gait (HP:0002136) | 2.94866652 |
| 20 | Limb dystonia (HP:0002451) | 2.94736069 |
| 21 | Progressive cerebellar ataxia (HP:0002073) | 2.90746234 |
| 22 | Blue irides (HP:0000635) | 2.76958159 |
| 23 | Atonic seizures (HP:0010819) | 2.76469227 |
| 24 | Ankle clonus (HP:0011448) | 2.73842340 |
| 25 | EEG with generalized epileptiform discharges (HP:0011198) | 2.73584769 |
| 26 | Intestinal atresia (HP:0011100) | 2.71312159 |
| 27 | Febrile seizures (HP:0002373) | 2.70439726 |
| 28 | Hypsarrhythmia (HP:0002521) | 2.68466270 |
| 29 | Epileptiform EEG discharges (HP:0011182) | 2.66973371 |
| 30 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.58943516 |
| 31 | Protruding tongue (HP:0010808) | 2.56586152 |
| 32 | Visual hallucinations (HP:0002367) | 2.55646667 |
| 33 | True hermaphroditism (HP:0010459) | 2.55354986 |
| 34 | Lissencephaly (HP:0001339) | 2.55208785 |
| 35 | Absence seizures (HP:0002121) | 2.54686384 |
| 36 | Abnormality of salivation (HP:0100755) | 2.53836291 |
| 37 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.52219476 |
| 38 | Pancreatic cysts (HP:0001737) | 2.50938542 |
| 39 | Pancreatic fibrosis (HP:0100732) | 2.50268913 |
| 40 | Pheochromocytoma (HP:0002666) | 2.50233005 |
| 41 | Nephronophthisis (HP:0000090) | 2.49274201 |
| 42 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.48372707 |
| 43 | Volvulus (HP:0002580) | 2.43894318 |
| 44 | Dialeptic seizures (HP:0011146) | 2.42904795 |
| 45 | Absent speech (HP:0001344) | 2.40122994 |
| 46 | Mutism (HP:0002300) | 2.40094456 |
| 47 | Abnormality of midbrain morphology (HP:0002418) | 2.36781173 |
| 48 | Molar tooth sign on MRI (HP:0002419) | 2.36781173 |
| 49 | Urinary urgency (HP:0000012) | 2.36313398 |
| 50 | Genital tract atresia (HP:0001827) | 2.35744669 |
| 51 | Vaginal atresia (HP:0000148) | 2.35109714 |
| 52 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.33921182 |
| 53 | Short 4th metacarpal (HP:0010044) | 2.33921182 |
| 54 | Macroorchidism (HP:0000053) | 2.33213871 |
| 55 | Action tremor (HP:0002345) | 2.31560874 |
| 56 | Anteriorly placed anus (HP:0001545) | 2.31264518 |
| 57 | Inappropriate behavior (HP:0000719) | 2.28826827 |
| 58 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.28352517 |
| 59 | Generalized tonic-clonic seizures (HP:0002069) | 2.28068804 |
| 60 | Chronic hepatic failure (HP:0100626) | 2.27682988 |
| 61 | Cortical dysplasia (HP:0002539) | 2.27290692 |
| 62 | Medial flaring of the eyebrow (HP:0010747) | 2.25332899 |
| 63 | Intention tremor (HP:0002080) | 2.22287019 |
| 64 | Papilledema (HP:0001085) | 2.21074005 |
| 65 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.20445919 |
| 66 | Dysmetria (HP:0001310) | 2.20162181 |
| 67 | Hepatoblastoma (HP:0002884) | 2.20133027 |
| 68 | Renal hypoplasia (HP:0000089) | 2.17810056 |
| 69 | Aqueductal stenosis (HP:0002410) | 2.16669081 |
| 70 | Optic nerve hypoplasia (HP:0000609) | 2.16483634 |
| 71 | Truncal ataxia (HP:0002078) | 2.16335898 |
| 72 | Hemiparesis (HP:0001269) | 2.15817366 |
| 73 | Scanning speech (HP:0002168) | 2.15530461 |
| 74 | Lower limb muscle weakness (HP:0007340) | 2.15518653 |
| 75 | Megalencephaly (HP:0001355) | 2.15200211 |
| 76 | Midline defect of the nose (HP:0004122) | 2.15076369 |
| 77 | Widely spaced teeth (HP:0000687) | 2.13314830 |
| 78 | Pachygyria (HP:0001302) | 2.12712597 |
| 79 | Colon cancer (HP:0003003) | 2.12372852 |
| 80 | Cutaneous syndactyly (HP:0012725) | 2.11622891 |
| 81 | Polyphagia (HP:0002591) | 2.10868325 |
| 82 | Hypoglycemic seizures (HP:0002173) | 2.10151717 |
| 83 | Congenital primary aphakia (HP:0007707) | 2.09359950 |
| 84 | Amyotrophic lateral sclerosis (HP:0007354) | 2.09097620 |
| 85 | Abnormality of the renal medulla (HP:0100957) | 2.05975886 |
| 86 | Progressive inability to walk (HP:0002505) | 2.03360061 |
| 87 | Morphological abnormality of the middle ear (HP:0008609) | 2.03245338 |
| 88 | Vitreoretinal degeneration (HP:0000655) | 2.02526614 |
| 89 | Nephrogenic diabetes insipidus (HP:0009806) | 2.00824657 |
| 90 | Narrow forehead (HP:0000341) | 1.99721042 |
| 91 | Paraplegia (HP:0010550) | 1.99630095 |
| 92 | Anophthalmia (HP:0000528) | 1.99428541 |
| 93 | Exotropia (HP:0000577) | 1.98729885 |
| 94 | Thickened helices (HP:0000391) | 1.98238354 |
| 95 | Cupped ear (HP:0000378) | 1.96929188 |
| 96 | Gastroesophageal reflux (HP:0002020) | 1.96897793 |
| 97 | Generalized hypopigmentation of hair (HP:0011358) | 1.95416512 |
| 98 | Abnormal hair whorl (HP:0010721) | 1.95099191 |
| 99 | Postaxial hand polydactyly (HP:0001162) | 1.95034429 |
| 100 | Neuroendocrine neoplasm (HP:0100634) | 1.94358617 |
| 101 | Gait imbalance (HP:0002141) | 1.94227586 |
| 102 | Abnormality of the pubic bones (HP:0003172) | 1.93827479 |
| 103 | Neoplasm of the oral cavity (HP:0100649) | 1.93636971 |
| 104 | Micropenis (HP:0000054) | 1.91636915 |
| 105 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.90534524 |
| 106 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.89896611 |
| 107 | Clonus (HP:0002169) | 1.88741917 |
| 108 | Open mouth (HP:0000194) | 1.87835156 |
| 109 | Hypoplasia of the brainstem (HP:0002365) | 1.87632298 |
| 110 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.87632298 |
| 111 | Absent eyebrow (HP:0002223) | 1.87461494 |
| 112 | Spastic paraplegia (HP:0001258) | 1.86277493 |
| 113 | Septo-optic dysplasia (HP:0100842) | 1.86146185 |
| 114 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.85536001 |
| 115 | Partial agenesis of the corpus callosum (HP:0001338) | 1.85300219 |
| 116 | Split foot (HP:0001839) | 1.84878245 |
| 117 | Bifid tongue (HP:0010297) | 1.84200834 |
| 118 | Oligodactyly (hands) (HP:0001180) | 1.83698017 |
| 119 | Papillary thyroid carcinoma (HP:0002895) | 1.83554274 |
| 120 | Patellar aplasia (HP:0006443) | 1.83098554 |
| 121 | Depression (HP:0000716) | 1.81720568 |
| 122 | Abnormality of the ischium (HP:0003174) | 1.81363999 |
| 123 | Parakeratosis (HP:0001036) | 1.81245945 |
| 124 | Dysdiadochokinesis (HP:0002075) | 1.80425443 |
| 125 | Symptomatic seizures (HP:0011145) | 1.79500703 |
| 126 | Neuronal loss in central nervous system (HP:0002529) | 1.79128923 |
| 127 | Anxiety (HP:0000739) | 1.78983947 |
| 128 | Poor coordination (HP:0002370) | 1.78706111 |
| 129 | Medulloblastoma (HP:0002885) | 1.78565701 |
| 130 | Labial hypoplasia (HP:0000066) | 1.78306788 |
| 131 | Genetic anticipation (HP:0003743) | 1.77373450 |
| 132 | Astrocytoma (HP:0009592) | 1.77370171 |
| 133 | Abnormality of the astrocytes (HP:0100707) | 1.77370171 |
| 134 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.77217423 |
| 135 | Specific learning disability (HP:0001328) | 1.76905520 |
| 136 | Cutaneous finger syndactyly (HP:0010554) | 1.76668195 |
| 137 | Inability to walk (HP:0002540) | 1.76668140 |
| 138 | Preaxial hand polydactyly (HP:0001177) | 1.76482401 |
| 139 | Abnormality of the 4th metacarpal (HP:0010012) | 1.75716472 |
| 140 | Cystic liver disease (HP:0006706) | 1.75372923 |
| 141 | Scrotal hypoplasia (HP:0000046) | 1.74822420 |
| 142 | Hyperthyroidism (HP:0000836) | 1.73806618 |
| 143 | High anterior hairline (HP:0009890) | 1.73283039 |
| 144 | Gastrointestinal atresia (HP:0002589) | 1.72850917 |
| 145 | Myelomeningocele (HP:0002475) | 1.72812391 |
| 146 | Abnormality of the labia minora (HP:0012880) | 1.72511211 |
| 147 | Relative macrocephaly (HP:0004482) | 1.72504669 |
| 148 | Intellectual disability, moderate (HP:0002342) | 1.72448848 |
| 149 | Anencephaly (HP:0002323) | 1.72374433 |
| 150 | Postaxial foot polydactyly (HP:0001830) | 1.72343035 |
| 151 | Postural instability (HP:0002172) | 1.71991179 |
| 152 | Retinal dysplasia (HP:0007973) | 1.71138332 |
| 153 | Fair hair (HP:0002286) | 1.71018712 |
| 154 | Abnormal eating behavior (HP:0100738) | 1.70590673 |
| 155 | Diplopia (HP:0000651) | 1.70349619 |
| 156 | Abnormality of binocular vision (HP:0011514) | 1.70349619 |
| 157 | Preaxial foot polydactyly (HP:0001841) | 1.68427788 |
| 158 | Thyroid-stimulating hormone excess (HP:0002925) | 1.67978271 |
| 159 | Abnormality of the antihelix (HP:0009738) | 1.67516078 |
| 160 | Tubulointerstitial nephritis (HP:0001970) | 1.66434093 |
| 161 | Hypoplastic labia majora (HP:0000059) | 1.64912685 |
| 162 | Gaze-evoked nystagmus (HP:0000640) | 1.64790880 |
| 163 | Occipital encephalocele (HP:0002085) | 1.64477215 |
| 164 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.64226170 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 5.44737540 |
| 2 | CASK | 3.21954198 |
| 3 | NTRK3 | 2.84515922 |
| 4 | MAP3K9 | 2.69156920 |
| 5 | TRIM28 | 2.36969343 |
| 6 | MAP3K4 | 2.36709398 |
| 7 | MAPK13 | 2.21994022 |
| 8 | NTRK2 | 2.12608702 |
| 9 | WNK3 | 2.11730649 |
| 10 | STK39 | 2.11608475 |
| 11 | CSNK1G2 | 2.02198273 |
| 12 | MAP3K2 | 1.78978755 |
| 13 | CSNK1G3 | 1.77239811 |
| 14 | PNCK | 1.73845109 |
| 15 | MKNK2 | 1.73511095 |
| 16 | OXSR1 | 1.72823399 |
| 17 | BCR | 1.72415315 |
| 18 | NTRK1 | 1.68731391 |
| 19 | UHMK1 | 1.67591515 |
| 20 | INSRR | 1.66968411 |
| 21 | MAP4K2 | 1.65568297 |
| 22 | PAK6 | 1.63277464 |
| 23 | EPHA4 | 1.55656857 |
| 24 | KSR1 | 1.55571329 |
| 25 | PKN1 | 1.53770578 |
| 26 | CSNK1G1 | 1.51619857 |
| 27 | CSNK1A1L | 1.51530460 |
| 28 | FGFR2 | 1.48788167 |
| 29 | MINK1 | 1.44193837 |
| 30 | FRK | 1.43732318 |
| 31 | PAK3 | 1.43730003 |
| 32 | MAP2K7 | 1.40118394 |
| 33 | EPHA3 | 1.35877859 |
| 34 | DYRK2 | 1.35756360 |
| 35 | MKNK1 | 1.31287584 |
| 36 | TNIK | 1.28014227 |
| 37 | CDK5 | 1.24075104 |
| 38 | ERBB3 | 1.19906659 |
| 39 | PHKG1 | 1.16438006 |
| 40 | PHKG2 | 1.16438006 |
| 41 | KSR2 | 1.15345286 |
| 42 | PRKD3 | 1.14217269 |
| 43 | CAMK1G | 1.13117159 |
| 44 | WNK1 | 1.10419972 |
| 45 | SCYL2 | 1.09746980 |
| 46 | WNK4 | 1.05965663 |
| 47 | MAP2K4 | 1.05854228 |
| 48 | SGK494 | 1.01565341 |
| 49 | SGK223 | 1.01565341 |
| 50 | DAPK2 | 1.00327589 |
| 51 | SIK2 | 0.99018563 |
| 52 | PINK1 | 0.97680784 |
| 53 | LATS1 | 0.96190425 |
| 54 | DYRK3 | 0.95892779 |
| 55 | CAMK2B | 0.95556895 |
| 56 | MARK2 | 0.91037837 |
| 57 | CAMK2A | 0.89737680 |
| 58 | ACVR1B | 0.88438581 |
| 59 | FGR | 0.87978135 |
| 60 | STK11 | 0.87772888 |
| 61 | ERBB4 | 0.85733465 |
| 62 | DYRK1A | 0.85185940 |
| 63 | ADRBK2 | 0.84555351 |
| 64 | SRPK1 | 0.83989460 |
| 65 | PRPF4B | 0.83916496 |
| 66 | PLK2 | 0.81730398 |
| 67 | BMPR1B | 0.81083427 |
| 68 | NUAK1 | 0.81000716 |
| 69 | AKT3 | 0.78544510 |
| 70 | PRKCE | 0.77872932 |
| 71 | RET | 0.76433094 |
| 72 | CCNB1 | 0.75477006 |
| 73 | SGK1 | 0.75214840 |
| 74 | STK38L | 0.72428527 |
| 75 | PRKCH | 0.71958822 |
| 76 | CDK3 | 0.71136799 |
| 77 | LIMK1 | 0.70723977 |
| 78 | EPHB2 | 0.70433666 |
| 79 | SGK2 | 0.70413080 |
| 80 | PLK4 | 0.69459501 |
| 81 | CSNK1D | 0.67071073 |
| 82 | CDK19 | 0.65861684 |
| 83 | CAMKK2 | 0.65538006 |
| 84 | FER | 0.65303542 |
| 85 | YES1 | 0.63564273 |
| 86 | BRD4 | 0.63547539 |
| 87 | PRKCG | 0.62899928 |
| 88 | ICK | 0.62872253 |
| 89 | CAMK2D | 0.61158761 |
| 90 | HIPK2 | 0.60247402 |
| 91 | FGFR1 | 0.57623572 |
| 92 | GRK5 | 0.57172576 |
| 93 | PRKCZ | 0.56913344 |
| 94 | WEE1 | 0.56754989 |
| 95 | CDC42BPA | 0.56160627 |
| 96 | TYRO3 | 0.54748853 |
| 97 | ERBB2 | 0.54489491 |
| 98 | CDK14 | 0.54414819 |
| 99 | CAMK1D | 0.53643380 |
| 100 | FYN | 0.53418622 |
| 101 | RPS6KA4 | 0.53164861 |
| 102 | TAF1 | 0.51769845 |
| 103 | PRKG1 | 0.50786658 |
| 104 | CDK18 | 0.50533218 |
| 105 | SGK3 | 0.50436537 |
| 106 | CDK15 | 0.50200786 |
| 107 | GRK1 | 0.50158986 |
| 108 | RPS6KA3 | 0.49586368 |
| 109 | GSK3A | 0.48058364 |
| 110 | ALK | 0.48032355 |
| 111 | CAMK2G | 0.47988811 |
| 112 | MAP3K13 | 0.47477418 |
| 113 | MET | 0.45041141 |
| 114 | BRSK2 | 0.44554711 |
| 115 | MAPK10 | 0.44450592 |
| 116 | PLK3 | 0.44325392 |
| 117 | NEK6 | 0.44134679 |
| 118 | ADRBK1 | 0.43651349 |
| 119 | CAMK4 | 0.43156003 |
| 120 | PRKCB | 0.40774050 |
| 121 | CDC7 | 0.40558180 |
| 122 | CSNK1E | 0.39452738 |
| 123 | ATM | 0.39392288 |
| 124 | ROCK2 | 0.39034934 |
| 125 | PDGFRB | 0.37282294 |
| 126 | RPS6KA2 | 0.37058492 |
| 127 | GSK3B | 0.36808525 |
| 128 | VRK1 | 0.36684564 |
| 129 | PRKACB | 0.36662831 |
| 130 | CDK11A | 0.35609816 |
| 131 | TGFBR1 | 0.35323365 |
| 132 | ZAK | 0.34598944 |
| 133 | PRKDC | 0.33469471 |
| 134 | MAPK9 | 0.33145784 |
| 135 | CSNK1A1 | 0.33049351 |
| 136 | DYRK1B | 0.32498392 |
| 137 | PRKAA1 | 0.31195558 |
| 138 | NEK2 | 0.30654689 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.93328481 |
| 2 | GABAergic synapse_Homo sapiens_hsa04727 | 2.35628867 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.33430168 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.18846498 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.11395575 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.08901149 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.08306247 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.02926463 |
| 9 | Insulin secretion_Homo sapiens_hsa04911 | 2.02826035 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 1.98401291 |
| 11 | Cocaine addiction_Homo sapiens_hsa05030 | 1.94025763 |
| 12 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.90460228 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.88900758 |
| 14 | Axon guidance_Homo sapiens_hsa04360 | 1.85294597 |
| 15 | Long-term potentiation_Homo sapiens_hsa04720 | 1.83644941 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.82725083 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.82130073 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.81624909 |
| 19 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.79234547 |
| 20 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.73599864 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.66876410 |
| 22 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.62139660 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.61618354 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.61198398 |
| 25 | Olfactory transduction_Homo sapiens_hsa04740 | 1.54790218 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.49958688 |
| 27 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.48401975 |
| 28 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.47696132 |
| 29 | Protein export_Homo sapiens_hsa03060 | 1.38353579 |
| 30 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.38055567 |
| 31 | Basal transcription factors_Homo sapiens_hsa03022 | 1.36021367 |
| 32 | Salivary secretion_Homo sapiens_hsa04970 | 1.34971707 |
| 33 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.34175354 |
| 34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.29016022 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.28699055 |
| 36 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.27803867 |
| 37 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.25712875 |
| 38 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.24183122 |
| 39 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.21529860 |
| 40 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.18916532 |
| 41 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.17364356 |
| 42 | Gap junction_Homo sapiens_hsa04540 | 1.16772643 |
| 43 | Circadian rhythm_Homo sapiens_hsa04710 | 1.13226897 |
| 44 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.11990873 |
| 45 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.10716072 |
| 46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.10287747 |
| 47 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.09510908 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.08708264 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.08257575 |
| 50 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05600707 |
| 51 | RNA degradation_Homo sapiens_hsa03018 | 1.05564985 |
| 52 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03019985 |
| 53 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.02723875 |
| 54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.97223151 |
| 55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.96718757 |
| 56 | Melanogenesis_Homo sapiens_hsa04916 | 0.95249153 |
| 57 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.93390269 |
| 58 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.91594847 |
| 59 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.90882723 |
| 60 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.89822948 |
| 61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.88219202 |
| 62 | Alcoholism_Homo sapiens_hsa05034 | 0.85569576 |
| 63 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85270230 |
| 64 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.84976105 |
| 65 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.84527280 |
| 66 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84282565 |
| 67 | Phototransduction_Homo sapiens_hsa04744 | 0.84091004 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83807335 |
| 69 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.83647876 |
| 70 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.83144838 |
| 71 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.83065390 |
| 72 | Glioma_Homo sapiens_hsa05214 | 0.81894072 |
| 73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80321539 |
| 74 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.79292914 |
| 75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.78699778 |
| 76 | Adherens junction_Homo sapiens_hsa04520 | 0.77487630 |
| 77 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77011827 |
| 78 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.74546185 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74337181 |
| 80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73689397 |
| 81 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73639829 |
| 82 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.71946508 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69113926 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68991398 |
| 85 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67466289 |
| 86 | * Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.66846547 |
| 87 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.65948419 |
| 88 | Bile secretion_Homo sapiens_hsa04976 | 0.65534113 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64981234 |
| 90 | Prion diseases_Homo sapiens_hsa05020 | 0.64292186 |
| 91 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.63227907 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62617226 |
| 93 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.62474226 |
| 94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.62050698 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60880810 |
| 96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60285693 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59845848 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.58427296 |
| 99 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.58377283 |
| 100 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.57177923 |
| 101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57057891 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55876734 |
| 103 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.53366143 |
| 104 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.52285769 |
| 105 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51911671 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51319757 |
| 107 | Melanoma_Homo sapiens_hsa05218 | 0.49238802 |
| 108 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49203601 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.48488759 |
| 110 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.47873981 |
| 111 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.46988606 |
| 112 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46625147 |
| 113 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46379318 |
| 114 | Tight junction_Homo sapiens_hsa04530 | 0.44852608 |
| 115 | RNA transport_Homo sapiens_hsa03013 | 0.44438301 |
| 116 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.43530772 |
| 117 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.41345674 |
| 118 | Colorectal cancer_Homo sapiens_hsa05210 | 0.40990048 |
| 119 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.40780332 |
| 120 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38853297 |
| 121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38196030 |
| 122 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.37111828 |
| 123 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36576983 |
| 124 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.36481992 |
| 125 | Cell cycle_Homo sapiens_hsa04110 | 0.35702595 |
| 126 | Lysine degradation_Homo sapiens_hsa00310 | 0.34133630 |
| 127 | Endocytosis_Homo sapiens_hsa04144 | 0.33475625 |
| 128 | ABC transporters_Homo sapiens_hsa02010 | 0.32792544 |
| 129 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.32393507 |
| 130 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32241211 |
| 131 | Phagosome_Homo sapiens_hsa04145 | 0.32215988 |
| 132 | Mineral absorption_Homo sapiens_hsa04978 | 0.30997548 |
| 133 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30352649 |
| 134 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.29008427 |
| 135 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28770530 |

